Clinical and Operational Value of Host Response Testing with Evidence-Based Insights from MeMed BV

In this recorded ADLM 2026 Industry Sponsored Workshop, experts explore how host response testing in acute infection and suspected sepsis can support more confident, high-value clinical decision-making. The session highlights the evolving role of the clinical laboratory as a strategic partner to clinicians, helping connect diagnostic insights with measurable operational and clinical value.

Through scientific context, real-world evidence, and implementation examples, the workshop examines how laboratories have integrated the MeMed BV host response test into routine workflows, supported stakeholder alignment, and helped advance consistent adoption across care settings.

Workshop objectives:

• Describe the biological basis and clinical role of host response tests in acute infection assessment
• Review real-world evidence demonstrating use of the MeMed BV assay across different care settings
• Discuss laboratory-led strategies for implementation, stakeholder alignment, and sustained clinical adoption

Speakers:

Moderator: Melissa Naiman, PhD, Sr. Director Medical & Scientific Affairs, Beckman Coulter

Speaker: Octavia M. Peck Palmer, PhD, Division Director, Clinical Chemistry; Vice Chair of Health Equity, Diversity & Inclusion; Associate Professor of Pathology

Speaker: Ike Northern, MT (ASCP), SM, Director of Infectious Disease Testing and Immunology, CompuNet Clinical Lab

Speaker: Suzane Silbert, PhD, Director, Esoteric Testing, Microbiology and Research Laboratories; Assistant Professor, Division of Infectious Disease, USF Health Morsani College of Medicine, Tampa General Hospital

Watch the recorded ADLM 2026 workshop to learn how host response testing with MeMed BV can support acute infection assessment, suspected sepsis workflows, and antimicrobial stewardship in acute and emergency care settings.

MAPSS-3151-US-EN-v1